Journal article
IL-23 favours outgrowth of spondyloarthritis-associated pathobionts and suppresses host support for homeostatic microbiota
LM Rehaume, N Matigian, AM Mehdi, N Lachner, KL Bowerman, J Daly, KA Lê Cao, P Hugenholtz, R Thomas
Annals of the Rheumatic Diseases | BMJ PUBLISHING GROUP | Published : 2019
Abstract
Objectives Certain gut bacterial families, including Bacteroidaceae, Porphyromonadaceae and Prevotellaceae, are increased in people suffering from spondyloarthropathy (SpA), a disease group associated with IL23R signalling variants. To understand the relationship between host interleukin (IL)-23 signalling and gut bacterial dysbiosis in SpA, we inhibited IL-23 in dysbiotic ZAP-70-mutant SKG mice that develop IL-23-dependent SpA-like arthritis, psoriasis-like skin inflammation and Crohn's-like ileitis in response to microbial beta 1,3-glucan (curdlan). Methods We treated SKG mice weekly with anti-IL-23 or isotype mAb for 3 weeks, rested them for 3 weeks, then administered curdlan or saline. W..
View full abstractGrants
Awarded by NHMRC
Funding Acknowledgements
The study was supported by NHMRC grant 1071822 and grants-in-aid from Arthritis Australia. RT was supported by Arthritis Queensland and NHMRC Research Fellowship. AMM was supported by JDRF Postdoctoral Fellowship. KALC was supported by NHMRC Career Development Fellowship and PH was supported by ARC Laureate Fellowship.